Docetaxel injection — supplier from India to the UK, GCC and Africa.
A taxane chemotherapy for breast, prostate, lung, gastric and head-and-neck cancers. 20mg, 80mg and 120mg concentrate for infusion, from 31 Indian WHO-GMP manufacturer lines, with the regulatory dossier and batch evidence a hospital procurement lead can sign off.
31 manufacturer lines · 20/80/120 mg · CTD dossier on file.
Active ingredient
Docetaxel (semi-synthetic taxane, disrupts microtubule dynamics during mitosis, arresting cell division in M-phase).
Strengths stocked
20mg/0.5ml, 80mg/2ml and 120mg/3ml concentrate for solution for infusion, single-use vials. Hospital packs and specials packs both available.
Indications covered
Adjuvant and metastatic breast cancer, castration-resistant prostate cancer, non-small-cell lung cancer, gastric adenocarcinoma, squamous-cell head-and-neck cancer. Regimens include TC, TAC, AC-T, TCH, TCF, DCF.
Storage
2-25°C (specifics on the SmPC), protected from light. Unopened vials are not frozen. Reconstituted infusion solution: used within 4 hours (2-8°C).
Shelf life
24 months on the concentrate. Minimum 18 months remaining at the point of dispatch to you.
Pack format
Single vial per carton. Outer shipper built to IATA and CAP guidance; passive temperature control validated to 72 hours, extendable to 120 hours on request.
Hospital pharmacies, importers and tender desks across twelve markets.
India is our origin. We do not supply docetaxel into the Indian market. Export only.
United Kingdom
Hospital pharmacies via specialist importers or directly under the MHRA specials / named-patient pathway. Particularly useful when the registered NHS supply sits in shortage notices and an alternative WHO-GMP docetaxel is needed against a named patient.
GCC (UAE, KSA, Kuwait, Oman, Qatar, Bahrain)
Routed through licensed local importers against hospital purchase orders and MoH tender awards. CTD dossiers prepared for national MoH registration and GCC central registration at SFDA.
Nigeria, Kenya, Ghana, South Africa
Public-sector tenders (NAFDAC, KEMSA, CMS Ghana, SAHPRA-licensed wholesalers) and teaching-hospital oncology wards. WHO-PQ pathway supported where specified.
Germany
Via licensed German importers under §72 AMG with Qualified Person release on arrival. CTD and CoPP prepared for BfArM recognition.
What arrives with every docetaxel consignment.
CoA and MoA, per batch
HPLC assay, related substances, water content by Karl Fischer, residual solvents, sterility, endotoxin. Signed by the manufacturer's authorised QC head.
CTD Module 3
Full chemistry, manufacturing and controls section, in eCTD-ready format where the importing authority accepts it.
CoPP + WHO-GMP + MFG licence
Issued by CDSCO (India) and apostilled where the destination authority requires it.
Destination-format artwork
SmPC-style labelling for UK, MoH format for GCC, SAHPRA for South Africa, BfArM for Germany. Artwork QC before print, not after.
Cold-chain data
Pre-shipment thermal validation, in-transit continuous logging, on-arrival inspection record. Excursion protocol agreed before dispatch.
Pharmacovigilance
Local PV partner or named PV contact organised in the destination market against registration. PSURs compiled to ICH E2C on request.
Five steps. Quote inside one working day.
- Send the specifics. Strength (20/80/120 mg), vial volume, destination market, tender or hospital pharmacy, target delivery window.
- We match to the right line. 31 docetaxel lines on the roster. Registered-market preference goes to lines with in-country registration; tender work goes to the right price-to-quality match.
- Commercial + regulatory offer. FOB / CIF price, lead time, dossier status per destination, expected documentation pack.
- Order, produce, release, ship. QC release on the Indian side. Cold-chain dispatch, continuous temperature monitoring, arrival inspection.
- After delivery. Batch records and thermal logs archived for the full shelf life. PV contact opened on registration.
Docetaxel supply — the specific questions.
What strengths of docetaxel do you supply?
20mg/0.5ml, 80mg/2ml and 120mg/3ml concentrate for solution for infusion, in single-use vials. Hospital packs and specials packs both available.
Which regimens is this docetaxel typically used in?
TC and TAC in adjuvant breast cancer; AC-T in neoadjuvant; TCH where trastuzumab is combined for HER2-positive disease; TCF / DCF in gastric and head-and-neck; as monotherapy in mCRPC. The docetaxel component is supplied by us; other agents are sourced separately by the hospital.
Is docetaxel in shortage in the UK and how does that affect supply?
Docetaxel has intermittently appeared on MHRA and Specialist Pharmacy Service shortage lists. We supply UK hospitals under the specials / named-patient route during shortages, with batch documentation prepared to MHRA expectations. See named-patient import, UK.
Do you supply docetaxel against NHS tender frameworks?
Yes, through UK-licensed wholesale partners. We compile the pricing, regulatory status notes and batch documentation pack the framework response template expects.
What documentation comes with the consignment?
Batch-specific CoA, MoA, CoPP where required, WHO-GMP certificate, manufacturing licence, Certificate of Origin (chamber-attested), destination-language pack insert, cold-chain temperature logs.
Do you provide CTD dossiers?
Yes — CTD Module 3 for MHRA, GCC central registration, national MoH, BfArM and equivalents. Module 2 and Module 1 prepared in destination format. See dossier preparation.
What are typical lead times?
Registered markets with stock: 5-10 working days. Made-to-order: 6-10 weeks. Air-freight UK/GCC: 3-5 days transit; sea-freight Africa: 18-28 days.
Is there a minimum order quantity?
No hard MOQ for named-patient or specials orders. For hospital and tender supply, economics typically start at 300-500 vials per dispatch, depending on destination.
Strength, volume, destination. Quote inside one working day.
Whether it's a shortage-fix for an NHS hospital, a GCC hospital PO, or a bulk tender for Nigeria — the same enquiry form. The same Mumbai desk.